Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center ...
Tags: Trevena, GPCR biased ligands, BLAST-AHF, acute heart failure
Clinical-stage pharmaceutical company Adynxx has obtained the US Food and Drug Administration (FDA) fast track designation for its AYX1 injection, which is used for prevention of chronic pain. In a five-cohort, dose-escalating study ...
Clinical-stage pharmaceutical company Cempra has received a notification of patent allowance from the US Patent and Trademark Office (USPTO) for taksta loading dose formulation. With the possibility for extension, the patent entitled ...
Cempra, a clinical-stage pharmaceutical company, has signed an exclusive license and development agreement for solithromycin with Toyama Chemical, a subsidiary of Fujifilm Holdings in Japan. As per the terms of the license and development ...
Tags: Cempra, Toyama Chemical, pharmaceutical
Karolinska Development has said that a syndicate led by Rosetta Capital will acquire a minority share in Karolinska's holdings in 13 of its 25 portfolio companies for SEK 220m($33.5m). As part of the transaction, the company will transfer ...
Tags: Karolinska Development, transaction, portfolio company, technology assets